Abivax (ABVX) EBITDA (2024 - 2026)
Abivax (ABVX) recorded quarterly EBITDA of -$65.8 million in Q1 2026, up 21.12% quarter-over-quarter from -$83.5 million in Q4 2025, and down 32.59% on a YoY basis from -$97.7 million in Q1 2025.
Abivax (ABVX) EBITDA (2024 - 2026) Analysis & Trends
Abivax's EBITDA history runs 3 years deep, the most recent figure standing at -$65.8 million for Q1 2026.
- In Q1 2026, EBITDA fell 32.59% year-over-year to -$65.8 million; the TTM figure through Mar 2026 stood at -$296.3 million (down 57.12% YoY), while the FY2025 annual figure was -$286.5 million, down 54.96% from the prior year.
- EBITDA was -$65.8 million for Q1 2026 at Abivax, up from -$83.5 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$38.0 million in Q2 2024 to a low of -$94.4 million in Q3 2025.
- Historically, EBITDA has averaged -$59.3 million across 3 years, with a median of -$52.6 million in 2025.
- Biggest YoY gain for EBITDA was 2.31% in 2025; the steepest drop was 82.41% in 2025.
- A 3-year view of EBITDA shows it stood at -$45.8 million in 2024, then sank by 82.41% to -$83.5 million in 2025, then climbed by 21.12% to -$65.8 million in 2026.
- The last three EBITDA figures came in at -$65.8 million (Q1 2026), -$83.5 million (Q4 2025), and -$94.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 661.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.83 Mn |
| Dec 31, 2025 | -83.45 Mn |
| Sep 30, 2025 | -94.36 Mn |
| Jun 30, 2025 | -52.63 Mn |
| Mar 31, 2025 | -49.65 Mn |
| Dec 31, 2024 | -45.75 Mn |
| Sep 30, 2024 | -55.12 Mn |
| Jun 30, 2024 | -38.04 Mn |
| Mar 31, 2024 | -48.53 Mn |